The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Programmed death-1 blockade in mismatch repair deficient colorectal cancer.
 
Dung T. Le
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Merck
 
Jennifer N. Uram
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Bjarne Bartlett
No Relationships to Disclose
 
Holly Kemberling
No Relationships to Disclose
 
Aleksandra Eyring
No Relationships to Disclose
 
Nilofer Saba Azad
Honoraria - Merck
Consulting or Advisory Role - Dava Oncology
Research Funding - Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Genentech (Inst); Kinex (Inst); Precision Biologics (Inst)
Travel, Accommodations, Expenses - Merck
 
Dan Laheru
No Relationships to Disclose
 
Ross C. Donehower
No Relationships to Disclose
 
Todd S. Crocenzi
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; Immunovative Therapies; kanghong Pharma; Lilly; Merck; Momenta Pharmaceuticals; Novo Nordisk; Pfizer; Sirtex Medical; Taiho Pharmaceutical; Targovax
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Celgene; ipsen
Research Funding - Bristol-Myers Squibb (Inst); EpicentRx (Inst); Genentech/Roche (Inst); Newlink Genetics (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); Tercica (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
James J. Lee
No Relationships to Disclose
 
Tim F. Greten
No Relationships to Disclose
 
Minori Koshiji
Employment - Merck
 
SoonMo Peter Kang
Employment - Merck
 
Robert A Anders
No Relationships to Disclose
 
James R. Eshleman
Patents, Royalties, Other Intellectual Property - Palb2 gene testing licensed to Myriad
 
Bert Vogelstein
Stock and Other Ownership Interests - Inostics; Morphotek; PapGene, Inc.; Personal Genome Diagnostics
Honoraria - Johnson & Johnson
Consulting or Advisory Role - Camden Partners; Inostics; Morphotek; PapGene, Inc.; Personal Genome Diagnostics
Research Funding - BioMed Valley Discoveries
Patents, Royalties, Other Intellectual Property - BioMed Valley Discoveries; Exact Sciences; Good Start Genetics; Inostics; Morphotek; Personal Genome Diagnostics; Roche; Thermo
 
Luis A. Diaz
Leadership - Personal Genome Diagnostics
Stock and Other Ownership Interests - PapGene, Inc.; Personal Genome Diagnostics
Consulting or Advisory Role - Merck; Personal Genome Diagnostics
Patents, Royalties, Other Intellectual Property - PapGene, PGDx and other entities have licensed several patent applications from Johns Hopkins, where Dr. Diaz is an inventor. These relationships are subject to certain restrictions under Johns Hopkins University policy, and the terms of these arrangement